Delivery of therapeutic proteins into tissues and across the blood-brain ba
rrier is severely limited by the size and biochemical properties of the pro
teins. Here it is shown that intraperitoneal injection of the 120-kilodalto
n beta-galactosidase protein, fused to the protein transduction domain from
the human immunodeficiency virus TAT protein, results in-delivery of the b
iologically active fusion protein to all tissues in mice, including the bra
in. These results open new possibilities for direct delivery of proteins in
to patients in the context of protein therapy, as well as for epigenetic ex
perimentation with model organisms.